Ex Parte GRAF et al - Page 8




          Appeal No.2003-0078                                        Page 8           
          Application No.09/257,066                                                   


          inherent for different amphoteric surfactants (reply brief, page            
          6), no evidence to substantiate that any two or all of the                  
          amphoteric surfactants listed in Table 1b of Falk ‘967 do in fact           
          have the same temperature resistance has been furnished by                  
          appellants.  Appellants are in the best position to provide such            
          evidence.  Unsupported arguments of counsel simply cannot take              
          the place thereof.  See In re Pearson, 494 F.2d 1399, 1405, 181             
          USPQ 641, 646 (CCPA 1974).                                                  
               Appellants also contend that the specification examples                
          furnish indicia of unobviousness. To the extent that appellants             
          are asserting that the examples establish unexpected results for            
          the claimed composition, we note that the question as to whether            
          unexpected advantages have been demonstrated is a factual                   
          question.  In re Johnson, 747 F.2d 1456, 1460, 223 USPQ 1260,               
          1263 (Fed. Cir. 1984).  Thus, it is incumbent upon appellants to            
          supply the factual basis to rebut the prima facie case of                   
          obviousness established by the examiner.  See, e.g., In re                  
          Klosak, 455 F.2d 1077, 1080, 173 USPQ 14, 16 (CCPA 1972).                   
          Appellants, however, do not provide an adequate explanation                 
          regarding any factual showing in the specification referred to in           
          the briefs to support a conclusion of unexpected advantages.                









Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  Next 

Last modified: November 3, 2007